ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,910.18
-0.75%
S&P 500
5,308.13
0.00%
Dow Jones
39,806.77
0.00%
US Dollar vs Yen
156.1965
-0.12%
Brent Oil
82.765
-0.92%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Sonoma Pharmaceuticals Inc (SNOA)

  7. Sonoma Pharmaceuticals Inc (SNOA) ニュース

SNOA

Sonoma Pharmaceuticals (SNOA)

Sonoma Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SNOA
日付受信時刻ニュースソース見出しコード企業名
2024/03/0906 : 29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
2024/03/0906 : 27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNOASonoma Pharmaceuticals Inc
2024/02/0906 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
2024/01/1021 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
2024/01/1006 : 47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/12/3007 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/12/3007 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/12/3007 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/12/3007 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/12/3007 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/12/1607 : 30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/11/2114 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/11/1406 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/11/0405 : 30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/10/3020 : 30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/10/2713 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/10/1406 : 19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/10/1205 : 30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/10/1120 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/09/2905 : 41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/09/2122 : 35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/09/2005 : 30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/08/1105 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/07/2805 : 30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/07/2206 : 00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/07/1506 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/07/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/07/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
2023/06/2205 : 17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
2023/05/1020 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNOA

最近閲覧した銘柄

NASDAQ
AMZN
Amazon.com
FX
USDGBP
US Dollar vs Sterling
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
NYSE
MRK
Merck
SPI
SP500
S&P 500
AMEX
SPY
SPDR S&P 500
FX
USDEUR
US Dollar vs Euro
NASDAQ
AAPL
Apple
USOTC
RHHBY
Roche (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
CCOM
US30
US 30
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
CCOM
US100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有